Director
DIN: 08802201
Rajat Rajendrakumar Rathi is currently associated with 2 companies in various capacities such as Designated Partner and Individual Promoter. They serve as a Director at ULTROZ TECHNOLOGIES LLP and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 08802201.Rajat Rajendrakumar Rathi has previously been associated with 1 company in roles such as Director.Rajat Rajendrakumar Rathi is currently involved in 2 different roles. Their most recent position is with ULTROZ BIOTECH PRIVATE LIMITED as a Individual Promoter. The first company Rajat Rajendrakumar Rathi was appointed to was ULTROZ TECHNOLOGIES LLP. Rajat Rajendrakumar Rathi is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Rajat Rajendrakumar Rathi is currently associated with 2 companies in various capacities such as Designated Partner and Individual Promoter. They serve as a Director at ULTROZ TECHNOLOGIES LLP and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 08802201.Rajat Rajendrakumar Rathi has previously been associated with 1 company in roles such as Director.Rajat Rajendrakumar Rathi is currently involved in 2 different roles. Their most recent position is with ULTROZ BIOTECH PRIVATE LIMITED as a Individual Promoter. The first company Rajat Rajendrakumar Rathi was appointed to was ULTROZ TECHNOLOGIES LLP. Rajat Rajendrakumar Rathi is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
2
Male
India
Call +91 81049 46419 and we'll pull the verified contact details for you.
Current Companies (1)
Current LLPs (1)
Past Companies (1)
1y 3m 8 Months Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| ULTROZ BIOTECH PRIVATE LIMITED | Individual Promoter | 09-Nov-2022 |